Nuora / Requested page
Nuora is waiting for the requested page to respond.
Women's Health
Internal proof mode
Menopause symptom review, HRT suitability screening, and pharmacist-led follow-up before any treatment decision.
Internal evaluation · No patient pathway open
Internal evaluation
Governance review
No patient intake
No treatment offered
Proof governance
Menopause symptom review, HRT suitability screening, and pharmacist-led follow-up before any treatment decision.
Governance model under reviewThese rows describe internal design inputs, not an available patient service.
Internal governance areas under review; no patient pathway is open.
Hot flushes, sleep, mood, bleeding, and treatment goals are captured together.
Cancer risk, bleeding red flags, blood pressure, and contraindications are reviewed.
Hormonal and non-hormonal options can be considered where clinically suitable.
Symptoms and safety factors are revisited after activation.
Internal review sequence
These stages describe the model being evaluated. No intake, treatment or follow-up pathway is open.
Assessment model
Model under review — Complete a menopause and symptom-history intake covering bleeding, risk factors, medicines, and goals.
Review model
Model under review — A clinician reviews suitability and identifies symptoms that need GP or specialist assessment.
Governance
Model under review — Where appropriate, receive an HRT or non-hormonal support plan with clear monitoring requirements.
Follow-up model
Model under review — Track symptoms and safety markers through scheduled reviews.
Criteria under review
These source criteria are not an open eligibility screen and do not begin patient care.
Internal evaluation only. No patient pathway is open.
Adults seeking menopause, perimenopause, or HRT support
No unexplained vaginal bleeding or urgent red-flag symptoms
Able to provide relevant screening, blood pressure, and medical history
Willing to complete symptom tracking and follow-up reviews
Internal proof mode
We are validating this pharmacist-review model internally before any public patient pathway opens.
This internal proof route does not accept patient intake or registration.
